Use Of Combined Oral Contraceptives For The Management Of Heavy Menstrual Bleeding

dc.creatorBahamondes L.
dc.creatorBahamondes M.V.
dc.date2011
dc.date2015-06-30T20:21:11Z
dc.date2015-11-26T14:48:18Z
dc.date2015-06-30T20:21:11Z
dc.date2015-11-26T14:48:18Z
dc.date.accessioned2018-03-28T21:59:03Z
dc.date.available2018-03-28T21:59:03Z
dc.identifier
dc.identifierExpert Review Of Obstetrics And Gynecology. , v. 6, n. 5, p. 485 - 489, 2011.
dc.identifier17474108
dc.identifier10.1586/eog.11.43
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-80053133777&partnerID=40&md5=a939406cd5dcf88e7c61531f2ee0aa09
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/107655
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/107655
dc.identifier2-s2.0-80053133777
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1253567
dc.descriptionEvaluation of: Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser I. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet. Gynecol. 117(4), 777-787 (2011). Heavy menstrual bleeding (HMB) is one of the most common reasons for women to seek gynecological care. Surgical and medical treatments have been proposed, including hysterectomy, endometrial ablation, oral progestins, the levonorgestrel-releasing intrauterine system, mefenamic acid and combined oral contraceptives (COCs). Although COCs have been used extensively to control HMB, there is little evidence of their efficacy. A new COC containing estradiol valerate and dienogest was compared with placebo in a randomized clinical trial that included women with objectively confirmed HMB in whom blood loss was measured using the alkaline hematin method. Over 6 months of treatment, results showed that blood loss decreased significantly in COC users, both when compared with a placebo group and with a 90-day pretreatment period. This represents a new option for HMB treatment with the advantage of simultaneously providing contraception, a requirement for many women with HMB who wish to preserve their fertility. Despite these excellent results, the facts remain that HMB is a chronic medical condition and that this new therapy still requires long-term evaluation. Notwithstanding, this report is the first to describe the successful use of a COC to treat HMB, a challenging condition with limited options for conservative treatment. © 2011 Expert Reviews Ltd.
dc.description6
dc.description5
dc.description485
dc.description489
dc.descriptionFraser, I.S., Critchley, H.O.D., Munro, M.G., Broder, M., A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding (2007) Fertility and Sterility, 87 (3), pp. 466-476. , DOI 10.1016/j.fertnstert.2007.01.023, PII S0015028207001331
dc.descriptionHallberg, L., Hogdahl, A., Nilsson, L., Rybo, G., Menstrual blood loss - A population study (1996) Acta. Obstet. Gynecol. Scand., 45, pp. 320-351
dc.descriptionBarnard, K., Frayne, S.M., Skinner, K.M., Sullivan, L.M., Health status among women with menstrual symptoms (2003) Journal of Women's Health, 12 (9), pp. 911-919
dc.descriptionCote, I., Jacobs, P., Cumming, D., Work loss associated with increased menstrual loss in the United States (2002) Obstetrics and Gynecology, 100 (4), pp. 683-687. , DOI 10.1016/S0029-7844(02)02094-X, PII S002978440202094X
dc.descriptionWu, J.M., Wechter, M.E., Geller, E.J., Nguyen, T.V., Visco, A.G., Hysterectomy rates in the United States, 2003 (2007) Obstetrics and Gynecology, 110 (5), pp. 1091-1095. , DOI 10.1097/01.AOG.0000285997.38553.4b, PII 0000625020071100000022
dc.descriptionWhiteman, M.K., Hillis, S.D., Jamieson, D.J., Inpatient hysterectomy surveillance in the United States, 2000-2004 (2008) Am. J. Obstet. Gynecol., 198, pp. 34e1-34e7
dc.descriptionKuppermann, M., Varner, R.E., Summitt Jr., R.L., Learman, L.A., Ireland, C., Vittinghoff, E., Stewart, A.L., Washington, A.E., Effect of Hysterectomy vs Medical Treatment on Health-Related Quality of Life and Sexual Functioning: The Medicine or Surgery (Ms) Randomized Trial (2004) Journal of the American Medical Association, 291 (12), pp. 1447-1455. , DOI 10.1001/jama.291.12.1447
dc.descriptionVessey, M.P., Villard-Mackintosh, L., McPherson, K., Coulter, A., Yeates, D., The epidemiology of hysterectomy: Findings in a large cohort study (1992) Br. J. Obstet. Gynaecol., 99, pp. 402-407
dc.descriptionLethaby, A., Shepperd, S., Cooke, I., Farquhar, C., Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding (2000) Cochrane Database Syst. Rev., 2, pp. CD000329
dc.descriptionKucuk, T., Ertan, K., Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: A randomized, prospective, controlled clinical trial in female smokers (2008) Clinical and Experimental Obstetrics and Gynecology, 35 (1), pp. 57-60
dc.descriptionKaunitz, A., Bissonnette, F., Monteiro, I., Lukkari-Lax, E., Muysers, C., Jensen, J.T., Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: A randomized controlled trial (2010) Obstet. Gynecol., 116, pp. 625-632. , erratum in: Obstet. Gynecol. 116, 999 (2010)
dc.descriptionMiddleton, L.J., Champaneria, R., Daniels, J.P., Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: Systematic review and meta-analysis of data from individual patients (2010) Br. Med. J., 341, pp. c3929
dc.descriptionBlumenthal, P.D., Dawson, L., Hurskainen, R., Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system (2011) Int. J. Gynecol. Obstet., 12, pp. 171-178
dc.descriptionAbbott, J.A., Garry, R., The surgical management of menorrhagia (2002) Human Reproduction Update, 8 (1), pp. 68-78. , DOI 10.1093/humupd/8.1.68
dc.descriptionNieboer, T.E., Johnson, N., Lethaby, A., Surgical approach to hysterectomy for benign gynaecological disease (2009) Cochrane Database Syst. Rev., 8, pp. CD003677
dc.descriptionHurskkainen Cooper, R., Mishra, G., Hardy, R., Kuh, D., Hysterectomy and subsequent psychological health: Findings from a British birth cohort study (2009) J. Affect. Disord., 115, pp. 122-130
dc.descriptionFarquhar, C., Brown, J., Oral contraceptive pill for heavy menstrual bleeding (2009) Cochrane Database Syst. Rev., 7, pp. CD000154
dc.descriptionFraser, I.S., McCarron, G., Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia (1991) Aust. NZ J. Obstet. Gynaecol., 31, pp. 66-70
dc.descriptionNilsson, L., Rybo, G., Treatment of menorrhagia (1971) Am. J. Obstet. Gynecol., 110, pp. 713-720
dc.descriptionJensen, J.T., Parke, S., Mellinger, U., MacHlitt, A., Fraser, I.S., Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: A randomized controlled trial (2011) Obstet. Gynecol., 117, pp. 777-787
dc.descriptionAhrendt, H.J., Makalova, D., Parke, S., Mellinger, U., Mansour, D., Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel (2009) Contraception, 80, pp. 436-444
dc.descriptionMishell Jr., D.R., Noncontraceptive benefits of oral contraceptives (1993) Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 38 (12 SUPPL.), pp. 1021-1029
dc.descriptionShabaan, M.M., Zakherah, M.S., El-Nashar, S.A., Sayed, G.A., Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: A randomized clinical trial (2011) Contraception, 83, pp. 48-54
dc.descriptionEndrikat, J., Shapiro, H., Lukkari-Lax, E., Kunz, M., Schmidt, W., Fortier, M., Canadian, A., Multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia (2009) J. Obstet. Gynaecol. Can., 31, pp. 340-347
dc.descriptionLethaby, A.E., Cooke, I., Rees, M., Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding (2005) Cochrane Database Syst. Rev., 4, pp. CD002126
dc.descriptionIrvine, G.A., Campbell-Brown, M.B., Lumsden, M.A., Heikkila, A., Walker, J.J., Cameron, I.T., Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia (1998) British Journal of Obstetrics and Gynaecology, 105 (6), pp. 592-598
dc.descriptionSasagawa, S., Shimizu, Y., Kami, H., Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile (2008) Steroids, 73, pp. 222-231
dc.description(2007) Heavy Menstrual Bleeding Commissioned by the National Institute for Health and Clinical Excellence, , www.nice.org.uk/nicemedia/pdf/CG44FullGuideline.pdf, National collaborating centre for womens and childrens health
dc.languageen
dc.publisher
dc.relationExpert Review of Obstetrics and Gynecology
dc.rightsfechado
dc.sourceScopus
dc.titleUse Of Combined Oral Contraceptives For The Management Of Heavy Menstrual Bleeding
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución